课题基金 / 基金详情

Environmental factors and compounds affecting the genomic stability in haploinsufficient BRCA1 cells.

Environmental factors and compounds affecting the genomic stability in haploinsufficient BRCA1 cells.
影响单倍体 BRCA1 细胞基因组稳定性的环境因素和化合物。
批准号:
10735532
负责人:
Jeannine Gerhardt
金额:
$111.4万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-07 至 2026-08-31

项目摘要

项目成果

Jeannine Gerhardt的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT Germline mutations in the BRCA1 gene are associated with higher risk of carcinogenesis. This high risk is linked to an increased mutation rate and loss of the second unaffected BRCA allele (loss of heterozygosity, LOH). It is well accepted that both environmental and genetic factors contribute to cancer etiology in BRCA1 carriers. However, knowledge about the biological mechanisms and environmental factors that influence the genomic stability in haploinsufficient BRCA1 cells is still lacking. In addition, dietary agents that avert mutagenesis and cancer, in particular estrogen receptor (ER)-negative cancer development in BRCA1 carriers are not known. It was reported that haploinsufficient BRCA1 cells obtained from BRCA1 carriers exhibit deficient repair of stalled replication. Our preliminary results show an increase replication defects and a rise in DNA breaks in haploinsufficient BRCA1 cells exposed to novel environmental factors, which were not described so far to cause genomic instability, in BRCA1 carrier cells. In addition, our preliminary data reveal a new dietary agent that can reduce DNA damage and increase the genomic stability in haploinsufficient BRCA1 cells. This proposal will investigate in aim 1 and 2 how environmental factors cause DNA replication and repair defects that lead to mutations and cancer cell development in haploinsufficient BRCA1 breast epithelial cells. And in aim 3 this study will identify novel dietary agents that are able to prevent these defects and reduce mutagenesis in haploinsufficient ER-negative BRCA1 cells. In summary, the experiments in this proposal will detect toxins that affect the genomic stability and new chemopreventive agents that avert defects and mutagenesis in haploinsufficient BRCA1 breast epithelial cells. Identification of chemopreventive agents, which avoid mutagenesis and LOH in haploinsufficient BRCA1 cells, would be extremely important for BRCA1 carriers.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.xpro.2023.102721
发表时间: 2023-12-15
期刊: STAR PROTOCOLS
影响因子: --
作者: [Madireddy, Advaitha, Gerhardt, Jeannine]
通讯作者: Gerhardt, Jeannine
Identification of compounds stabilizing the GAA repeats in Friedreich’s ataxia cells
海外基金